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Abstract
Background: The interleukin 17A (IL-17A) which is located on chromosome 6p and has been linked to chronic
inflammation, is an important candidate gene conferring coal workers’ pneumoconiosis (CWP). The purpose of this
study was to investigate the genetic association between single nucleotide polymorphisms (SNPs) of IL-17A and
CWP in a Chinese population.
Methods: We conducted a case–control study to investigate the role of four common SNPs in the IL-17A gene, and
evaluated the relationship between these four SNPs and dust-exposure year, tobacco smoking and stages of CWP.
A total of 1391 subjects was enrolled in this study, including 694 subjects in control group and 697 in case group.
TaqMan based qRT-PCRs were taken to genotype rs2275913, rs3748067, rs4711998, and rs8193036 within the IL-17A
gene. Luciferase assays were used to determine the effects of rs8193036 C > T alleles on the expression of IL-17A.
Results: Unconditional logistic regression analysis showed that the genotypes of rs3748067 AA (adjusted OR = 0.43,
95 % CI = 0.23–0.83) and rs8193036 TT (adjusted OR = 0.59, 95 % CI = 0.40–0.86) were associated with a decreased
risk of CWP, particularly among subgroups of smokers (adjusted OR =0.34, 95 % CI = 0.13–0.86 for rs3748076; adjusted
OR = 0.41, 95 % CI = 0.23–0.71 for 8193036) and CWP cases with stage I (adjusted OR = 0.45, 95 % CI = 0.21–0.98 for
rs3748076; adjusted OR = 0.46, 95 % CI = 0.28–0.74 for 8193036). Furthermore, the polymorphism of rs3748067
significantly reduced the CWP risk among cases with over 27 years of dust exposure (adjusted OR = 0.42, 95 %
CI = 0.18–0.97). The luciferase assays in two cell lines showed that the rs8193036 C > T substitution could reduce
the expression of IL-17A, which was consistent with the findings of our association study.
Conclusions: The rs3748067 G > A and rs8193036 C > T polymorphisms decrease CWP risk. These findings could
be helpful in identifying individuals at decreased risk for CWP and further studies are warranted to validate them.
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Background
Coal workers’ pneumoconiosis (CWP), common oc-
curred in underground coal miners, is one of the most
prevalent occupational diseases in China. CWP is char-
acterized by chronic lung inflammation and formation of
fibrotic nodular lesions that results from the inhalation
of airborne coal mining dust which usually contains free
crystalline silica [1, 2]. CWP is a kind of progressive and
irreversible fibrotic lung diseases without any effective
therapy. It was reported that cytokines, such as trans-
forming growth factor-β1 (TGF-β1), interleukin (IL)-1β,
IL-6 and IL-13, were produced by alveolar macrophages
to promote lung inflammation after silica inhalation.
Persistent inflammation was converted into lung fibrosis
eventually [3, 4]. Many factors are related to the preva-
lence of CWP, including the long time exposure to high
concentrations of respirable crystalline silica [5, 6], poor
personal protection and individual susceptibility [7].
Interleukin-17A (IL-17A) is a cytokine with strong
pro-inflammatory effect and has been reported to be ele-
vated in fibrotic disorders [8, 9]. IL-17A is important for
host defense against extracellular pathogens and it can
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lead to drastic inflammatory responses by recruiting
neutrophils and other cytokines [10]. Thus, IL-17A may
play a crucial role in the inflammation of silicosis [11].
IL-17A is produced by a subset of CD4+ T-helper (Th)
cells, Th17 cells, which are distinct from the classic Th1
and Th2 cells. Therefore, IL-17A plays an important role
in both innate and adaptive immunities [12, 13]. How-
ever, IL-17A is secreted not only by Th17 cells, but by
γδ T-cells and natural killer T-cells as well [14, 15]. Pre-
vious studies about IL-17A in CWP were rare whereas
the effect of IL-17A in lung inflammation and fibrosis
was definite. Increased levels of IL-17A have been dem-
onstrated in bronchoalveolar lavage (BAL) of patients
with IPF and lung tissues exposed to BLM and IL-1β
[16]. Neutralization of IL-17A could delay the progres-
sion of silica-induced lung inflammation and fibrosis in
C57BL/6 mice [17, 18]. A huge number of studies have
identified the association between the IL-17A polymor-
phisms and risk for human disorders, such as pediatric
asthma [19], multiple sclerosis [20], gastric cancer [21],
and dilated cardiomyopathy [22]. In the present study,
we attempted to clarify the association between IL-17A
polymorphisms and CWP risk in a Chinese population.
Materials and methods
Study population
Our study population consisted of 697 CWP patients and
694 controls. They were recruited from the coal mines of
Xuzhou Mining Business Group Co., Ltd. between January
2006 and December 2010, as described previously [23].
Briefly, all participants were genetically unrelated Chinese
Han males and were underground coal miners who spent
their entire working career within the above mentioned
company. The subjects with clinical evidence of auto-
immunity diseases, had received immunosuppressive or
immunostimulatory therapy, or were subjected to radio-
therapy were excluded. High kilovolt chest X-ray and
physical examinations were performed based on the China
National Diagnostic Criteria for Pneumoconiosis (GBZ
70–2002), which are the same as that of the 1980 Inter-
national Labour Organization (ILO) in the judgment of
opacity profusion,to reconfirm the diagnoses [24] . Ac-
cording to the size, profusion, and distribution of opaci-
ties, all patients were classified into stage I, stage II or
stage III. The chest X-rays were assessed by at least two
independent physicians. The questionnaire for each par-
ticipant was conducted by the face-to-face interview using
a double-blind method. This epidemiological question-
naire focused on age, respiratory symptoms, occupational
histories, and smoking habits and some others. Blood
sample of 5 ml was obtained from each participant, and
was used for routine lab tests. The control subjects were
miners matched with the CWP cases for age, dust expos-
ure period, and job types from the same company in order
to make the dust exposure histories between cases and
controls were comparable. This study protocol was
specifically approved by the Institutional Review Board
of Nanjing Medical University and all subjects gave their
written informed consent before participating in the study.
Genotyping
Conventional phenol-chloroform method was used to
extract the genomic DNA from peripheral blood lym-
phocytes. Genotyping was performed using the TaqMan
method with the ABI 7900HT Real Time PCR system
according to the manufacturer’s instructions (Applied
Biosystem, Foster city, CA, USA) in a blinded fashion,
which means the people conducted the genotyping ex-
periment was unaware of the workers’ personal details
or case status. The sequences of primer and probe for
each SNP are available on request. Genomic DNA
(50 ng) was used for each reaction, and amplification
was performed under the following conditions: 50 °C for
2 min and 95 °C for 10 min followed by 45 cycles of 95 °
C for 15 sec and 60 °C for 1 min. Negative controls were
included in each plate to ensure accuracy of the geno-
typing. 10 % of the samples were randomly selected for
confirmation, and the results were 100 % concordant.
Cell culture
Human lung adenocarcinoma A549 cells and human
bronchial epithelial (HBE) cells were purchased from
the Shanghai Institute of Biochemistry and Cell Biology,
Chinese Academy of Science (Shanghai, China). Cells
were cultured in Dulbecco modified Eagle medium sup-
plemented with 100U/ml penicillin, 100 μg/ml strepto-
mycin, and 10 % fetal bovine serum. The cells were
grown at 37 °C in the presence of 5 % carbon dioxide
in a humidified incubator.
Construction of luciferase reporter plasmids
We constructed 2 luciferase reporter plasmids to explore
whether rs8193036C > T polymorphism had an effect on
IL-17A gene expression in vitro. The constructs of a 792-
bp DNA fragment corresponding to the upstream region
of the transcription start site of IL-17A, which were ampli-
fied from individual homozygous templates and were
cloned into the pGL3-basic luciferase vector (Promega,
Madision, WI). The vectors were then sequenced to con-
firm that there were no nucleotide errors.
Transient transfections and luciferase assays
A549 and HBE cells were seeded in 24-well plates, and
each well was transfected with 2.4 μg of the vector DNA
containing either C or T allele of rs8193036 and 0.08 μg of
pRL-SV40 which contains the Renilla luciferase gene by
Lipofectamine 2000 (Invitrogen, Carlsbad, CA), according
to the manufacture’s instruction. Cells were collected 48 h
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after transfection, and luciferase activity was measured
with a dual Luciferase reporter assay system (Promega)
and was normalized against the activity of the Renilla
luciferase gene. Independent triplicate experiments
were performed for each plasmid.
Statistical analyses
Differences in the distributions of demographic charac-
teristics, selected variables, and frequencies of genotypes
of IL-17A polymorphisms between the CWP cases and
controls were evaluated by using the Student’s t-test or
χ2-test. The Hardy-Weinberg equilibrium (HWE) was
tested using a goodness-of-fit χ2-test. The associations
between genotypes and CWP were estimated by comput-
ing odds ratios (ORs) and their 95 % confidence intervals
(CIs) from unconditional logistic regression analysis with
the adjustment for possible confounders.
The statistical power was calculated by using the PS
software (http://biostat.mc.vanderbilt.edu/twiki/bin/view/
Main/PowerSampleSize). For the stratified analysis, the
age and dust-exposure cutoff was according to the median
of age and dust-exposure years of the participants. All
statistical tests were two-sided at a significance level of
0.05 and were analyzed by the SAS software (version 9.1;
SAS Institute, Inc.,Cary, NC).
Results
Four IL-17A SNPs were genotyped in 697 CWP patients
and 693 controls. The information about frequency distri-
butions of the selected characteristics was summarized in
Table 1. There were no significant difference between the
cases and controls in the distribution of age (P = 0.103),
exposure years (P = 0.105), and job types (P = 0.534).
Although the smoking status of CWP was similar to the
controls (P = 0.250), the smoking amount (pack-years)
in CWP cases was significantly less than that of con-
trols (P < 0.001). The frequency distributions and means
of the selected characteristics were matched adequately
between cases and controls. Furthermore, of the 697
CWP cases, the pneumoconiosis stages from I to III
were 415 (59.5 %), 219 (31.4 %) and 63 (9.0 %).
The primary information and allele frequencies ob-
served were listed in Table 2. All genotyped distributions
of control subjects were consistent with those expected
from the Hardy-Weinberg equilibrium. The minor allele
frequencies (MAF) of these four polymorphisms were
consistent with that reported in the HapMap database
(http://www.hapmap.org).
Logistic regression analysis was performed to assess
the effect of each SNP on CWP risk (adjusting for age,
exposure years, job type, and pack-years of smoking).
Parameters for the association of SNPs with CWP were
Table 1 Demographic and selected variables among the CWP cases and controls
Variables CWP (n = 697) Controls (n = 694) P
Number Percent Number Percent
Age, year (mean ± SD) 68.0 ± 11.1 67.1 ± 8.4 0.103
Exposure years (mean ± SD) 26.6 ± 9.0 27.3 ± 7.8 0.105
Smoking status
Never 340 48.8 360 51.9 0.250
Ever 357 51.2 334 48.1
Former 163 23.4 91 13.1
Current 194 27.8 243 35.0
Pack-years smoked <0.001
0 340 49.2 360 52.6
0-20 223 32.0 132 19.0
>20 134 19.2 202 29.1
Work type 0.534
Tunnel and coal mining 663 95.1 652 94.0
Transport 16 2.3 17 2.5
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shown in Table 3. The analysis revealed that two SNPs
(rs3748067, rs8193036) of IL-17A were associated with
the risk of CWP significantly. It was revealed that the
variant allele decreased the susceptibility to CWP under
co-dominant (OR = 0.43, 95 % CI = 0.22–0.81, P = 0.010
for AA versus GG for rs3748067; OR = 0.60, 95 % CI =
0.41–0.87, P = 0.007 for TT versus CC for rs8193036), re-
cessive (OR = 0.44, 95 % CI = 0.23–0.83, P = 0.012 for
rs3748067; OR = 0.64, 95 % CI = 0.44–0.91, P = 0.014 for
rs8193036), and additive (OR = 0.82, 95 % CI = 0.67–0.99,
P = 0.012 for rs3748067; OR = 0.81, 95 % CI = 0.69–0.95,
P = 0.011 for rs8193036) models. These associations
remained significant after adjusting for age, exposure
years, and pack-years smoking. Carrying the A allele of
rs3748067 was associated with decreased risk (adjusted
OR = 0.81, 95 % CI = 0.66–0.99). Similarly, subjects with
the IL-17A rs8193036 T allele showed a lower decreased
risk relative to the C allele, with adjusted OR = 0.80, 95 %
CI = 0.68–0.95, respectively. However, no association was
found between rs2275913 G > A, rs4711098 A >G poly-
morphism and CWP occurrence.
We further investigated the effect of exposure years,
smoking status and stage of CWP on the association be-
tween IL-17A gene polymorphisms and CWP risk. As
shown in Table 4, the association between rs3748067
and CWP risk remained significant among subjects who
had longer than 27 years of exposure (OR = 0.42, 95 % CI
= 0.18–0.97, P = 0.041) under a recessive model. However,
the variants rs8193036 significantly decreased CWP risk
of individuals who had less than 27 years of exposure
(OR = 0.46, 95 % CI = 0.25–0.85, P = 0.014) under a reces-
sive model (Table 5). In addition, the variants rs3748067
and rs8193036 both significantly decreased CWP risk of
smokers (OR = 0.34, 95 % CI = 0.13-0.86, P = 0.022 for
rs3748067; OR = 0.41, 95 % CI = 0.23-0.71, P = 0.002 for
rs8193036) under a recessive model. Additionally, sig-
nificant associations were observed between the genotypes
and patients with stage I (OR = 0.45, 95 % CI = 0.21–0.98,
P =0.045 for rs3748067; OR = 0.46, 95 % CI = 0.28–0.75,
P =0.001 for rs8193036) under a recessive model. Fur-
thermore, case-control logistic regression analysis was
conducted to investigate the interaction between SNP
and smoking status. Nevertheless, no variants was
interacted with smoking status significantly (OR =0.71,
95 % CI = 0.20-2.56, P =0.596 for rs3748067; OR =0.60,
95 % CI = 0.29-1.24, P = 0.163 for rs8193036; Table 6).
In order to evaluate whether the IL-17A rs8193036
C > T polymorphism is associated with the transcrip-
tional activity of IL-17A, pGL3-basic vectors with either
rs8193036 C or rs8193036 T allele were constructed.
The above vectors were transfected into A549 or HBE
cells, respectively. As shown in Fig. 1, the vectors with
rs8193036 T allele reduced the relative luciferase activ-
ities significantly, compared with the rs8193036 C allele
in both of the cell lines (P < 0.05). These results sug-
gested that the rs8193036 T allele in the 5’UTR region
was associated with a decreased transcriptional activity
of IL-17A.
Discussion
This study was investigated to explore the probable rela-
tionship between IL-17A genetic variants and the sus-
ceptibility to CWP. We found a remarkable association
between two SNPs (rs3748067 and rs8193036) of IL-17A
gene and the resistance to the disease, and the associa-
tions were more evident in smokers. Similarly, subjects
carrying the rs3748067 AA and rs8193036 TT genotypes
had a moderately decreased risk of CWP patients with
stage I. Luciferase assays demonstrated that IL-17A
promoters with rs8193036 T allele decreased the tran-
scriptional activity of IL-17A, compare with rs8193036 C
allele, which was consistent with the findings in our
relevant study.
CWP is a serious occupational disease which is com-
mon occurred in underground coal miners. There is no
effective treatment for CWP currently. The incidence
and progression of CWP are determined by both dust
exposure levels [5] and silica content in the dust [24].
However, only few people exposed to coal dust or silica
developed CWP ultimately. Thus, characterization and
identification of genes involved in the genetic predispos-
ition or progression have an important role in clinical
settings for the treatment of CWP [25].
IL-17 is a cytokine released from Th17 and other IL-
17 producing cells, IL-17 cytokine family consists of six
members including IL-17A (IL-17), IL-17B, IL-17C, IL-
17D, IL-17E (also known as IL-25) and IL-17 F. Many
cells are IL-17A-responsive, such as epithelial cells,
endothelial cells, fibroblasts, macrophages, and dendritic
cells. Furthermore, Th17 cell and other cells which as
producers of IL-17A are also sensitive to the cytokine
[26]. IL-17A plays a crucial role in the development and
progression of both acute and chronic inflammation-
induced pulmonary fibrosis. It may modulate the inflam-
matory response and synthesis of collagen [17, 27]. In
addition, the elevated expression of IL-17A has been
Table 2 Primary information of genotyped SNPs in IL-17(IL-17
polymorphisms)




rs2275913 5’UTR G > A 0.440 0.435 0.393
rs3748067 3’UTR G > A 0.160 0.189 0.135
rs4711998 5’UTR A > G 0.284 0.285 0.852
rs8193036 5’UTR C > T 0.289 0.333 0.493
aHWE P value in the control group
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reported in animal models of fibrotic disease and in hu-
man fibrotic tissues, including lungs [28], livers [29], skin
[9] and others.
IL-17A participates in the pathogenesis of fibrotic dis-
orders maybe through three pathways. First, IL-17A can
regulate lung inflammation through an IL-1β dependent
mechanism [9]. A previous study has described that in-
nate IL-1β-IL-23-IL-17A axis in the establishment of
early pulmonary inflammation with direct consequences
on late evolution to fibrosis after lung injury. Their data
Table 3 Distributions of genotypes of IL-17 and their associations with risk of CWP
Variables CWP cases Controls Pa OR (95 % CI) Pb OR (95 % CI)b
Number Percent Number Percent
rs2275913 n =692 n = 687
GG 221 31.9 225 32.8 1.00 1.00
AG 333 48.1 326 47.5 0.749 1.04 (0.82-1.32) 0.665 1.05 (0.83-1.34)
AA 138 19.9 136 19.8 0.832 1.03 (0.76-1.40) 0.734 1.05 (0.78-1.43)
G allele 775 56.0 776 56.5 1.00 1.00
A allele 609 44.0 598 43.5 0.800 1.02 (0.88-1.19) 0.695 1.03 (0.89-1.20)
ADD 0.802 1.02 (0.88-1.18) 0.699 1.03 (0.88-1.20)
DOM 0.746 1.03 (0.83-1.30) 0.647 1.05 (0.84-1.32)
REC 0.946 1.01 (0.77-1.32) 0.880 1.02 (0.78-1.33)
rs3748067 n = 693 n = 690
GG 486 70.1 460 66.7 1.00 1.00
GA 193 27.8 199 28.8 0.476 0.92 (0.73-1.16) 0.408 0.90 (0.71-1.15)
AA 14 2.0 31 4.5 0.010 0.43 (0.22-0.81) 0.011 0.43 (0.23-0.83)
G allele 1165 84.1 1119 81.1 1.00 1.00
A allele 221 15.9 261 18.9 0.040 0.81 (0.67-0.99) 0.035 0.81 (0.66-0.99)
ADD 0.041 0.82 (0.67-0.99) 0.036 0.81 (0.67-0.99)
DOM 0.166 0.85 (0.68-1.07) 0.139 0.84 (0.67-1.06)
REC 0.012 0.44 (0.23-0.83) 0.014 0.44 (0.23-0.85)
rs4711998 n = 693 n = 689
AA 350 50.5 353 51.2 1.00 1.00
GA 293 42.3 279 40.5 0.610 1.06 (0.85-1.31) 0.558 1.06 (0.86-1.33)
GG 50 7.2 57 8.3 0.556 0.88 (0.59-1.33) 0.628 0.90 (0.60-1.36)
A allele 993 71.6 985 71.5 1.00 1.00
G allele 393 28.4 393 28.5 0.924 0.99 (0.84-1.17) 0.984 1.00 (0.85-1.18)
ADD 0.923 0.99 (0.84-1.17) 0.984 1.00 (0.85-1.18)
DOM 0.787 1.03 (0.83-1.27) 0.711 1.04 (0.84-1.29)
REC 0.462 0.86 (0.58-1.28) 0.518 0.88 (0.59-1.31)
rs8193036 n = 693 n = 690
CC 347 50.1 311 45.1 1.00 1.00
TC 292 42.1 298 43.2 0.252 0.88 (0.70-1.10) 0.233 0.87 (0.70-1.09)
TT 54 7.8 81 11.7 0.007 0.60 (0.41-0.87) 0.006 0.59 (0.40-0.86)
C allele 986 71.1 920 66.7 1.00
T allele 400 28.9 460 33.3 0.011 0.81 (0.69-0.95) 0.009 0.80 (0.68-0.95)
ADD 0.011 0.81(0.69-0.95) 0.009 0.81 (0.69-0.95)
DOM 0.062 0.82 (0.66-1.01) 0.053 0.81 (0.66-1.00)
REC 0.014 0.64 (0.44-0.91) 0.011 0.63 (0.43-0.90)
ADD wild homozygote versus heterozygote versus mutational homozygote, DOM wild homozygote versus heterozygote and mutational homozygote, REC wild
homozygote and heterozygote versus mutational homozygote
aTwo-sided χ2 test
bAdjusted for age, exposure years, jobtype, and pack-years of smoking in logistic regression model
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suggest that lung injury promotes IL-1β production
which increases IL-23 expression and in turn can
stimulate innate IL-17 expression [30]. Mark et al. [16]
identified that genetic deletion of IL-17A significantly
attenuated lung inflammation and fibrosis induced by
BLM treatment. Second, IL-17A can stimulate collagen
synthesis from fibroblasts, directly and/or indirectly, via
fibroblast production of cytokines such as TGF-β1 and
connective growth factor (CTGF) [17]. IL-17A in-
creased the synthesis and secretion of collagen and
promoted the epithelial-mesenchymal transition in al-
veolar epithelial cells in a TGF-β1 dependent manner
[17]. Taiji et al. [31] reported that the IL-17A signaling
pathway took an antifibrogenic effect in scleroderma
fibroblasts as intrinsic activation of TGF-β1 inhibits IL-
17A signaling by the down-regulation of the receptor
Table 4 Stratification analyses between the genotypes of rs3748067 and CWP risk
Variables Cases/controls Genotypes (cases/controls) Pa OR (95 % CI)a
GG/GA AA
n % n %
Total 693/690 679/659 98.0/95.5 14/31 2.0/4.5 0.014 0.44 (0.23-0.85)
Age
<68 276/405 270/388 97.8/95.8 6/17 2.2/4.2 0.040 0.33 (0.11-0.95)
≥68 417/285 409/271 96.9/95.1 8/14 1.9/4.9 0.041 0.68 (0.16-0.96)
Exposure years
<27 270/267 264/255 97.8/95.5 6/12 2.2/4.5 0.210 0.52 (0.19-1.44)
≥27 423/423 415/404 95.5/98.1 8/19 1.9/4.5 0.041 0.42 (0.18-0.97)
Smoking status
never 340/359 333/345 98.0/96.1 7/14 2.1/3.9 0.228 0.56 (0.22-1.43)
ever 353/331 346/214 am 7/17 2.0/5.1 0.022 0.34 (0.13-0.86)
Stage
I 415/690 406/659 97.8/95.5 9/31 2.2/4.5 0.045 0.45 (0.21-0.98)
II 217/690 212/659 97.7/95.5 5/31 2.3/4.5 0.199 0.52 (0.19-1.41)
III 61/690 61/659 100/95.5 0/31 0/4.5
aAdjusted for age, exposure years, jobtype, and pack-years of smoking in logistic regression model
Table 5 Stratification analyses between the genotypes of rs8193036 and CWP risk
Variables Cases/controls Genotypes (cases/controls) Pa OR (95 % CI)a
CC/TC TT
Number Percent Number Percent
Total 693/690 639/609 92.2/88.3 54/81 7.8/11.7 0.011 0.63 (0.43-0.90)
Age
<68 276/405 258/354 93.5/87.4 18/51 6.5/12.6 0.025 0.50 (0.27-0.92)
≥68 417/285 381/255 91.4/89.5 36/30 8.63/10.5 0.335 0.78 (0.47-1.30)
Exposure years
<27 270/267 253/233 93.7/82.3 17/34 6.3/12.7 0.014 0.46 (0.25-0.85)
≥27 423/423 386/376 91.3/88.9 37/47 8.8/11.1 0.227 0.75 (0.48-1.19)
Smoking status
never 340/359 309/319 90.9/88.9 31/40 9.1/11.1 0.448 0.82 (0.50-1.36)
ever 353/331 330/290 93.5/87.6 23/41 6.5/12.4 0.002 0.41 (0.23-0.71)
Stage
I 415/690 391/609 94.2/88.3 24/81 5.8/11.7 0.001 0.46 (0.28-0.74)
II 217/690 196/609 90.3/88.3 21/81 9.7/11.7 0.437 0.81 (0.48-1.37)
III 61/690 52/609 85.3/88.3 9/81 14.8/11.7 0.445 1.36 (0.62-2.96)
aAdjusted for age, exposure years, and pack-years of smoking in logistic regression model
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and contributed to the excess collagen accumulation
and tissue fibrosis via miR-129-5p. Third, IL-17A could
upregulate the expression of tissue inhibitor of
metalloproteinase-1 (TIMP-1), and inhibited extracellu-
lar matrix (ECM) degradation by matrix metallopro-
teinases (MMPs) effectively [32].
To our knowledge, this is the first evaluation of the as-
sociation between functional SNPs in IL-17A and CWP
susceptibility in a Chinese population. Based on the
above-mentioned studies, it seems that IL-17A may have
a vital role in the pathogenesis and development of
CWP. Investigation of IL-17A gene polymorphisms in
patients with CWP and controls showed that the inherit-
ance rate of rs3748067 AA genotype and rs8193036 TT
genotype were more frequent in the controls than in the
patients, thus they may be resistance factors for CWP.
Furthermore, stratification analyses were applied, and
each of these two SNPs (rs3748067 and rs8193036) sig-
nificantly decreased CWP risk of individuals who has
ever smoked.
Functional analyses of the 2 related IL-17A polymor-
phisms showed that rs8193036 C > T influenced lower
transcription of IL-17A in vitro. Rs3748067 was a locus
of expression for interferon regulatory factor 4 (IRF4), a
transcription factor that has been innumerable linked to
the transient inflammation and progressive fibrosis [33].
Rs8193036 may be located on a transcription factor binding
site (TFBS), affecting transcription activity and it may pre-
dispose individuals to fibrogenesis. These findings provide
new insights into the role of IL-17A in the pathogenesis
and development of CWP.
Several limitations of this present study should be con-
sidered. First, we matched the dust exposure levels by
job titles and exposure years between case and control,
and therefore, the selection bias could not be ruled out
and the subjects could not fully represent the general
populations of coal miners in China. Second, although
our study suggested that rs3748067 and rs8193036 varia-
tions of IL-17A gene were associated with the risk of
CWP, more biological background data and functional
studies are needed to explain the results. Third, the sam-
ple size of this study is relatively moderate, which may re-
duce the statistical power to find the other difference
between groups. Therefore, further large sample size stud-
ies with more diverse ethnic populations are required to
replicate our results.
Conclusion
Taken together, the present study first indicates that two
functional IL-17A SNPs (rs3748067 and rs8193036) are
associated with decreased risk of CWP in a Chinese popu-
lation, especially among the subgroup of smokers and pa-
tients with stage I. Further prospective study and strict
case–control study are warranted to confirm our findings.
Actually, the control of dust exposure in the workplace is
the only way to totally eliminate pneumoconiosis.
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